Chronic Endometritis
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Genesis TherapeuticsCA - Burlingame
2 programsIntrauterine infusionPHASE_21 trial
Oral antibiotic administrationPHASE_21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Genesis TherapeuticsIntrauterine infusion
Genesis TherapeuticsOral antibiotic administration
Human BioSciencesDead Sea Peloid Gel
Clinical Trials (3)
Total enrollment: 30 patients across 3 trials
Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis
Start: Jan 2021Est. completion: Apr 2024
Phase 2Unknown
Intrauterine Antibiotic Infusion in Treating Chronic Endometritis and Restoring Reproductive Dynamics
Start: Mar 2017Est. completion: Jan 2020
Phase 2Completed
Efficacy of Dead Sea Peloid Gel in Chronic Endometritis
Start: Jul 2011Est. completion: Jun 201330 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.